Does RIBOCICLIB Cause Metastatic neoplasm? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Metastatic neoplasm have been filed in association with RIBOCICLIB (KISQALI). This represents 0.1% of all adverse event reports for RIBOCICLIB.
31
Reports of Metastatic neoplasm with RIBOCICLIB
0.1%
of all RIBOCICLIB reports
9
Deaths
9
Hospitalizations
How Dangerous Is Metastatic neoplasm From RIBOCICLIB?
Of the 31 reports, 9 (29.0%) resulted in death, 9 (29.0%) required hospitalization, and 3 (9.7%) were considered life-threatening.
Is Metastatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIBOCICLIB. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does RIBOCICLIB Cause?
Neutropenia (3,585)
Nausea (3,404)
Fatigue (3,327)
Malignant neoplasm progression (2,468)
Death (2,452)
Vomiting (1,953)
Diarrhoea (1,830)
White blood cell count decreased (1,683)
Pain (1,637)
Metastases to bone (1,538)
What Other Drugs Cause Metastatic neoplasm?
BEVACIZUMAB (133)
TRASTUZUMAB (120)
CAPECITABINE (102)
PACLITAXEL (102)
CARBOPLATIN (89)
LEUPROLIDE (84)
DOCETAXEL (72)
ADALIMUMAB (71)
RANITIDINE (71)
DENOSUMAB (68)
Which RIBOCICLIB Alternatives Have Lower Metastatic neoplasm Risk?
RIBOCICLIB vs RIBOFLAVIN
RIBOCICLIB vs RIBOFLAVIN 5'-PHOSPHATE
RIBOCICLIB vs RIBOFLAVIN 5^-PHOSPHATE
RIBOCICLIB vs RIFABUTIN
RIBOCICLIB vs RIFAMPICIN